Tuesday, November 24, 2009, 2:48pm EST - Canadian Markets close in 1 hour and 12 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Volcano Corporation (VOLC)

At 14:33 EST: 15.45 USD  Up 0.24 (1.58%)  
MORE ON VOLC
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Volcano Corporation (NGM:VOLC) Delayed quote dataEdit
Last Trade: 15.45 USD
Trade Time: 2:33PM EST
Change: Up 0.24 (1.58%)
Prev Close: 15.21
Open: 15.25
Bid: 15.45 x 600
Ask: 15.47 x 300
1y Target Est: 20.50
Day's Range: 15.00 - 15.49
52wk Range: 11.33 - 17.80
Volume: 107,021
Avg Vol (3m): 323,803
Market Cap: 752.23M
P/E (ttm): N/A
EPS (ttm): -0.04
Div & Yield: N/A (N/A%)
Volcano Corporation (VOLC)
1d  5d  3m  6m  1y  2y  5y 
 Add VOLC to Portfolio   Download Data

HEADLINES
Volcano Corporation Presentation at Piper Jaffray Conference to be Webcast
PRNewswire (Tue 1:00pm)
Coverage initiated on Volcano by Morgan Joseph
Briefing.com (Tue, Nov 17)
VOLCANO CORP Financials
EDGAR Online Financials (Wed, Nov 11)
Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast
PRNewswire (Mon, Nov 9)
Volcano Beats
Zacks.com (Sat, Nov 7)
Volcano posts Q3 revenue of $54M
at bizjournals.com (Sat, Nov 7)
VOLCANO CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 6)
VOLCANO CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, Nov 5)
Volcano Reports 22 Percent Increase in Third Quarter Revenues COMPANY EXPERIENCES STRONG GROWTH ACROSS CORE BUSINESSES
PRNewswire (Thu, Nov 5)
Q3 2009 Volcano Corporation Earnings Release - Time Not Supplied
CCBN (Thu, Nov 5)
Volcano Corporation Schedules Third Quarter Conference Call, Webcast
PRNewswire (Mon, Oct 26)
More Headlines for VOLC...

ANALYST
EPS Est (next year) (Dec-07) : -0.10
EPS Est (in 2 years) (Dec-08) : 0.08
Avg Rec (current)*: 1.7
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Volcano Corporation engages in the development, manufacture, and commercialization of intravascular ultrasound (IVUS) and functional measurement (FM) products that are used for the diagnosis and treatment of vascular and structural heart disease.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices